US OptionsDetailed Quotes
AUTL250516C2500
- 0.02
- 0.000.00%
15min DelayClose Apr 25 16:00 ET
0.00High0.00Low
0.02Open0.02Pre Close0 Volume39 Open Interest2.50Strike Price0.00Turnover172.56%IV89.47%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier20DDays to Expiry0.02Extrinsic Value100Contract SizeAmericanOptions Type0.0921Delta0.3029Gamma66.50Leverage Ratio-0.0022Theta0.0001Rho6.13Eff Leverage0.0005Vega
Autolus Therapeutics Stock Discussion
Sign in to post a comment
$Autolus Therapeutics (AUTL.US)$ Autolus Therapeutics to Present Key Data on AUCATZYL At 2025 Tandem Meetings, Highlighting Cost Benefits and Clinical Outcomes! February 12 to 15, 2025
4
2
$Autolus Therapeutics (AUTL.US)$
Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024
Autolus Therapeutics (NASDAQ: AUTL)presented clinical data updates at ASH 2024, featuring one oral and three poster presentations about obecabtagene autoleucel (obe-cel) for relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL).
The FELIX trial demonstrated that obe-cel treatment achieved deep molecular remission in 84% of responde...
Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024
Autolus Therapeutics (NASDAQ: AUTL)presented clinical data updates at ASH 2024, featuring one oral and three poster presentations about obecabtagene autoleucel (obe-cel) for relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL).
The FELIX trial demonstrated that obe-cel treatment achieved deep molecular remission in 84% of responde...
1
$Autolus Therapeutics (AUTL.US)$ Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024 6 to 8 PM pst 12/9/24!
4 MINUTES AGO, 7:30 PM EST
VIA GLOBENEWSWIRE
4 MINUTES AGO, 7:30 PM EST
VIA GLOBENEWSWIRE
1
$Autolus Therapeutics (AUTL.US)$ Nothing happened?
2
1
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
$Autolus Therapeutics (AUTL.US)$
ya I'm getting in here
ya I'm getting in here
1
2
$Autolus Therapeutics (AUTL.US)$
Autolus Therapeutics Announces FDA Approval of AUCATZYL® (obecabtagene autoleucel – obe-cel) for adults with relapsed/refractory B-cell acute lymphoblastic leukemia (r/r B-ALL)
• AUCATZYL is the first CAR T therapy approved by the FDA with no requirement for a REMS program (Risk Evaluation Mitigation Strategy)
• Approval based on FELIX clinical trial of obe-cel in adult patients with r/r B-ALL
• Conference call to be held on November 11 at 08:30 am EST/13:3...
Autolus Therapeutics Announces FDA Approval of AUCATZYL® (obecabtagene autoleucel – obe-cel) for adults with relapsed/refractory B-cell acute lymphoblastic leukemia (r/r B-ALL)
• AUCATZYL is the first CAR T therapy approved by the FDA with no requirement for a REMS program (Risk Evaluation Mitigation Strategy)
• Approval based on FELIX clinical trial of obe-cel in adult patients with r/r B-ALL
• Conference call to be held on November 11 at 08:30 am EST/13:3...
3
No comment yet
blessings u : Thank you for sharing.
Trytosaveabit OP blessings u : you’re welcome![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")